Electrophysiology & Arrhythmia

A mathematical method to measure electrical communications within the heart has been shown to be useful in predicting the effectiveness of catheter ablation.

In a collaboration between digital healthcare company iRhythm and the Stanford Machine Learning Group (SMLG), an algorithm has been developed to detect 14 different cardiac output classes, including 12 arrhythmias.

New research from Monaco suggests that breast implants can impede electrocardiogram (ECG) recordings, leading to false readings and potentially incorrect heart attack diagnoses.

Researchers from Rice University and the Texas Heart Institute are introducing a wireless pacemaker that can be implanted directly into a patient’s heart at this week's IEEE’s International Microwave Symposium in Honolulu, running through June 9.

A new study by researchers at the University of Pennsylvania produced evidence that shows men’s lower resting heart rate could contribute to why they commit crimes at a higher rate.

Newly published research examined 3,868 atrial fibrillation (AFib) outcomes collected from the Danish Diet, Cancer and Health Study. Led by Morten Fenger-Grøn, MSc, with Aarhus University in Denmark, the study found no association between risk factors and obesity-related measurements, rather identifying lean body mass as the predominant driver of risk for AFib

The D-Heart, manufactured by Genova, Italy-based D-Heart Srl, developed a four-lead smartphone-based electrocardiogram (ECG). It is compatible with both iOS and Android operating systems and can stream results to any smartphone via Bluetooth.

The Heart Rhythm Society (HRS) recently announced the late-breaking clinical trials sessions for the upcoming Heart Rhythm scientific sessions.

An analysis conducted at the Munich Octoberfest found that acute alcohol consumption was associated with sinus tachycardia and other cardiac arrhythmias.

The need for permanent pacemakers in patients with severe aortic stenosis who undergo transcatheter aortic valve replacement (TAVR) remains a complication, even as TAVR expands into lower-risk groups. That may prove to be a limitation, especially with younger patients who may have decades of life ahead of them.

After adjusting for sociodemographics, health behaviors and clinical characteristics, patients with atrial fibrillation who had low health literacy were less likely to be aware of their diagnosis, according to an analysis of members from two large health insurance companies.

A meta-analysis of four randomized trials found that using primary prevention implantable cardioverter defibrillators (ICDs) decreased all-cause mortality by 25 percent in patients with nonischemic cardiomyopathy.